Müberra Devrim Güner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Müberra Devrim Güner has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Perihan Elif Ekmekci
Department of History of Medicine and Ethics, Faculty of Medicine, TOBB University of Economics and Technology, ANKARA, TÜRKİYE
6 shared publications Perihan Elif Ekmekci
TOBB Econ & Technol Univ, Dept Hist Med & Eth, Sch Med, Ankara, Turkey
4 shared publications- Banu Buruk
Donders Institute for Brain, Cognition and Behaviour Department of Human Centered Intelligent Systems, Radboud University, Nijmegen, The Netherlands
2 shared publications - Berra Kurtoglu
Gazi University, Turkey
2 shared publications - Perihan Elif Ekmekci
TOBB ETU School of Medicine
2 shared publications Perihan Elif Ekmekci̇
2 shared publications
Latest Publications
- 27 April 2026
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 28 (1) , 25-35
A MIXED-METHOD STUDY ON PERSPECTIVES OF PUBLIC AND PHARMACOVIGILANCE PROFESSIONALS ON THE USE OF SOCIAL MEDIA FOR ADVERSE DRUG REACTION REPORTING
Objective: Rare adverse drug reactions (ADRs) often go undetected in clinical trials, making post-marketing surveillance essential. Despite established pharmacovigilance (PV) systems, underreporting of ADRs persists. Social media (SM) has emerged as a potential tool for enhancing ADR reporting, though its integration raises ethical and practical concerns. Material and Methods: This mixed-methods study assessed the knowledge, attitudes, and ethical perspectives of patients, caregivers, and PV professionals (PVPs) regarding ADR reporting and the use of SM in PV activities. Results: Among 707 respondents, only 3.68% had full knowledge of national PV systems, and most had never reported an ADR. Barriers included uncertainty about the reporting process, lack of feedback, and perceived complexity. While SM was not a preferred reporting channel, respondents recognized its dual potential as both a source of support and misinformation. Focus group discussions reinforced these findings and highlighted the importance of ethical safeguards, including data privacy, informed consent, and content validation. Only 51 PVPs responded; most had limited ADR-reporting experience. Despite hesitations, both groups acknowledged that, with proper design and oversight, SM could support PV by raising awareness, facilitating communication, and enhancing data collection. Conclusion: SM is increasingly recognized as a potential source of real-world data for ADR monitoring, communication, and public education. Despite challenges such as misinformation, privacy concerns, and reporting quality, participants acknowledged the value of SM in enhancing PV efforts. Limited awareness of PV systems and underreporting highlight the need for broader public education. SM’s effective use in PV activities requires careful design, ethical oversight, and proactive stakeholder engagement.
- 27 April 2026
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 28 (1) , 25-35
A MIXED-METHOD STUDY ON PERSPECTIVES OF PUBLIC AND PHARMACOVIGILANCE PROFESSIONALS ON THE USE OF SOCIAL MEDIA FOR ADVERSE DRUG REACTION REPORTING
Objective: Rare adverse drug reactions (ADRs) often go undetected in clinical trials, making post-marketing surveillance essential. Despite established pharmacovigilance (PV) systems, underreporting of ADRs persists. Social media (SM) has emerged as a potential tool for enhancing ADR reporting, though its integration raises ethical and practical concerns. Material and Methods: This mixed-methods study assessed the knowledge, attitudes, and ethical perspectives of patients, caregivers, and PV professionals (PVPs) regarding ADR reporting and the use of SM in PV activities. Results: Among 707 respondents, only 3.68% had full knowledge of national PV systems, and most had never reported an ADR. Barriers included uncertainty about the reporting process, lack of feedback, and perceived complexity. While SM was not a preferred reporting channel, respondents recognized its dual potential as both a source of support and misinformation. Focus group discussions reinforced these findings and highlighted the importance of ethical safeguards, including data privacy, informed consent, and content validation. Only 51 PVPs responded; most had limited ADR-reporting experience. Despite hesitations, both groups acknowledged that, with proper design and oversight, SM could support PV by raising awareness, facilitating communication, and enhancing data collection. Conclusion: SM is increasingly recognized as a potential source of real-world data for ADR monitoring, communication, and public education. Despite challenges such as misinformation, privacy concerns, and reporting quality, participants acknowledged the value of SM in enhancing PV efforts. Limited awareness of PV systems and underreporting highlight the need for broader public education. SM’s effective use in PV activities requires careful design, ethical oversight, and proactive stakeholder engagement.
- 12 February 2022
- Published by Wiley in Developing World Bioethics
- Vol. 23 (1) , 23-33
Challenges and practices arising during public health emergencies: A qualitative survey on ethics committees
The particular dynamics of public health emergencies urge scientists and Ethics Committee (EC) members to change and adapt their operating procedures to function effectively. Despite having previous pandemic experiences, ethics committees were unprepared to adapt to COVID‐19 pandemic challenges. This survey aims to learn and thoroughly discuss the most salient issues for ECs during the COVID‐19 pandemic. The results indicate that the main problems faced by ECs were lack of/insufficient regulations, lack of data/experience/knowledge, sloppy review, poor research design, and poor adaptation to quarantine measures. Coping with factors that threaten the autonomy and independence of ECs, the ethical dilemma regarding maximizing common good versus protecting the rights and well‐being of study participants, comprehending the change in the context of vulnerable populations, and redefining the role of ECs to strengthen trust in science and vaccine confidence were outstanding issues.
- 12 February 2022
- Published by Wiley in Developing World Bioethics
- Vol. 23 (1) , 23-33
Challenges and practices arising during public health emergencies: A qualitative survey on ethics committees
The particular dynamics of public health emergencies urge scientists and Ethics Committee (EC) members to change and adapt their operating procedures to function effectively. Despite having previous pandemic experiences, ethics committees were unprepared to adapt to COVID‐19 pandemic challenges. This survey aims to learn and thoroughly discuss the most salient issues for ECs during the COVID‐19 pandemic. The results indicate that the main problems faced by ECs were lack of/insufficient regulations, lack of data/experience/knowledge, sloppy review, poor research design, and poor adaptation to quarantine measures. Coping with factors that threaten the autonomy and independence of ECs, the ethical dilemma regarding maximizing common good versus protecting the rights and well‐being of study participants, comprehending the change in the context of vulnerable populations, and redefining the role of ECs to strengthen trust in science and vaccine confidence were outstanding issues.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 17 (1) , 47-53
Variability of Pharmacogenomics Information in Drug Labels Approved by Different Agencies and its Ethical Implications
Aims: The aim of this study was to determine if there are discrepancies among various agency-approved labels for the same active ingredient and where the labels approved by the Turkish Medicines and Medical Devices Agency (TMMDA) stand regarding the inclusion of PGx and discuss these ethical implications. Background: The efficacy and safety of drugs can be improved by rational prescription and personalization of medicine for each patient. Pharmacogenomics information (PGx) in Drug Labels (DL) is one of the important tools for the personalization of medications because genetic differences may affect both drug efficacy and safety. Providing adequate PGx to patients has ethical implications. Objective: The study aims to evaluate PGx in the DLs approved by TMMDA and other national agencies provided by the Pharmacogenomics Knowledgebase. Methods: DL annotations from the Pharmacogenomics Knowledgebase and DLs approved by the TMMDA were analyzed according to information and action levels, which are "testing required", "testing reconunended", "actionable", and "informative". Results: There are 381 drugs listed in PharmGKB drug label annotations with pharmacogenomics information, and 278 of these have biomarkers. A total of 242 (63.5%) drugs are approved and available in Turkey. Of these, 207 (85.5%) contain the same information as in or similar to that in the labels approved by the other agencies. The presence and level of information varied among the DLs approved by different agencies. The inconsistencies may have an important effect on the efficacy and the safety of drugs. Conclusion: These findings suggest a need for the standardization of PGx information globally because it may not only affect the efficacy and safety of medications but also essential ethical rules regarding patient rights by violating not sufficiently sharing all available information.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 17 (1) , 47-53
Variability of Pharmacogenomics Information in Drug Labels Approved by Different Agencies and its Ethical Implications
Aims: The aim of this study was to determine if there are discrepancies among various agency-approved labels for the same active ingredient and where the labels approved by the Turkish Medicines and Medical Devices Agency (TMMDA) stand regarding the inclusion of PGx and discuss these ethical implications. Background: The efficacy and safety of drugs can be improved by rational prescription and personalization of medicine for each patient. Pharmacogenomics information (PGx) in Drug Labels (DL) is one of the important tools for the personalization of medications because genetic differences may affect both drug efficacy and safety. Providing adequate PGx to patients has ethical implications. Objective: The study aims to evaluate PGx in the DLs approved by TMMDA and other national agencies provided by the Pharmacogenomics Knowledgebase. Methods: DL annotations from the Pharmacogenomics Knowledgebase and DLs approved by the TMMDA were analyzed according to information and action levels, which are "testing required", "testing reconunended", "actionable", and "informative". Results: There are 381 drugs listed in PharmGKB drug label annotations with pharmacogenomics information, and 278 of these have biomarkers. A total of 242 (63.5%) drugs are approved and available in Turkey. Of these, 207 (85.5%) contain the same information as in or similar to that in the labels approved by the other agencies. The presence and level of information varied among the DLs approved by different agencies. The inconsistencies may have an important effect on the efficacy and the safety of drugs. Conclusion: These findings suggest a need for the standardization of PGx information globally because it may not only affect the efficacy and safety of medications but also essential ethical rules regarding patient rights by violating not sufficiently sharing all available information.
- Open Access
- 13 September 2021
- Published by Wiley in Developing World Bioethics
- Vol. 22 (4) , 217-230
Comparison of COVID‐19 studies registered in the clinical trial platforms: A research ethics analysis perspective
Background: The coronavirus disease (COVID‐19) treatment must be based on scientific methods such as clinical trials. Trials involving human subjects and those requiring a risk‐benefit analysis may occasionally face challenges owing to the time limitations in the pandemic.Methodology: This study analyses the WHO's International Clinical Trials Registry Platform and clinicaltrials.gov, where most COVID‐19 clinical trials are registered, according to ethical criteria including study design, conflicts of interest, enrollment of healthcare workers, study locations, site‐, design‐, and participant‐related issues. The discussion is based on three aspects: the quality of the information to be produced, the relevance to significant health problems, and the creation or evaluation of interventions, policies, or practices that promote individual or public health.Results: There were significant differences between the two platforms regarding the investigational medicinal product (IMP), the comparator, ethics committee/institutional review board approval, plan to share individual participant data, study phase, site, IMP, and design‐related issues. Conflict of interest, sponsor information, and management of vulnerable groups were the main areas wherein both platforms lacked sufficient information.Conclusion: With this analysis, we aimed to define a minimum set of ethical criteria for clinical trial platforms to obtain standardization between these two platforms.
- 13 September 2021
- Published by Wiley in Developing World Bioethics
- Vol. 22 (4) , 217-230
Open AccessComparison of COVID‐19 studies registered in the clinical trial platforms: A research ethics analysis perspective
Background: The coronavirus disease (COVID‐19) treatment must be based on scientific methods such as clinical trials. Trials involving human subjects and those requiring a risk‐benefit analysis may occasionally face challenges owing to the time limitations in the pandemic.Methodology: This study analyses the WHO's International Clinical Trials Registry Platform and clinicaltrials.gov, where most COVID‐19 clinical trials are registered, according to ethical criteria including study design, conflicts of interest, enrollment of healthcare workers, study locations, site‐, design‐, and participant‐related issues. The discussion is based on three aspects: the quality of the information to be produced, the relevance to significant health problems, and the creation or evaluation of interventions, policies, or practices that promote individual or public health.Results: There were significant differences between the two platforms regarding the investigational medicinal product (IMP), the comparator, ethics committee/institutional review board approval, plan to share individual participant data, study phase, site, IMP, and design‐related issues. Conflict of interest, sponsor information, and management of vulnerable groups were the main areas wherein both platforms lacked sufficient information.Conclusion: With this analysis, we aimed to define a minimum set of ethical criteria for clinical trial platforms to obtain standardization between these two platforms.
- Open Access
- 1 September 2021
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 49 (6) , 477-487
Ethical evaluation of informed consent forms used in cardiology clinics and the importance of institutional standardized approach
Objective: This study aimed to evaluate the content of informed consent forms (ICFs) used during cardiology interventions by the university, research and training (R&T), and private hospitals with regard to ethical standards and compare them with the Turkish Society of Cardiology (TSC) templates and among various institutions. Methods: A total of 185 forms from the university, R&T, and private hospitals and 19 TSC templates were selected and analyzed for 26 criteria. Compliance with TSC templates was also evaluated. Data were presented as the percent-age of ICFs satisfying the criteria and compared using the Fisher exact test, and 95% confidence intervals were calculated. Results: TSC templates were more compatible and included more information to comply with ethical standards than ICFs of all 3 types of healthcare institutions. The areas of improvement for these templates were prospects of treatment and alternative treatments, quality of life, explanation for third-party consent, duration of hospitalization, and time to return to normal life. Among the 3 types of hospitals, R&T-ICFs were more compatible with templates. Private hospital ICFs had the poorest compliance with TSC templates. Separate anesthesia ICFs and detailed information about exposure to radioactivity were lacking. Conclusion: The current ICFs for cardiology interventions have major ethical deficiencies and need urgent improvement. Professional societies such as TSC are essential institutions to develop and provide guidance and templates for ICFs to meet the ethical standards during the informed consent process and standardization of the process among various institutions.
- 1 September 2021
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 49 (6) , 477-487
Open AccessEthical evaluation of informed consent forms used in cardiology clinics and the importance of institutional standardized approach
Objective: This study aimed to evaluate the content of informed consent forms (ICFs) used during cardiology interventions by the university, research and training (R&T), and private hospitals with regard to ethical standards and compare them with the Turkish Society of Cardiology (TSC) templates and among various institutions. Methods: A total of 185 forms from the university, R&T, and private hospitals and 19 TSC templates were selected and analyzed for 26 criteria. Compliance with TSC templates was also evaluated. Data were presented as the percent-age of ICFs satisfying the criteria and compared using the Fisher exact test, and 95% confidence intervals were calculated. Results: TSC templates were more compatible and included more information to comply with ethical standards than ICFs of all 3 types of healthcare institutions. The areas of improvement for these templates were prospects of treatment and alternative treatments, quality of life, explanation for third-party consent, duration of hospitalization, and time to return to normal life. Among the 3 types of hospitals, R&T-ICFs were more compatible with templates. Private hospital ICFs had the poorest compliance with TSC templates. Separate anesthesia ICFs and detailed information about exposure to radioactivity were lacking. Conclusion: The current ICFs for cardiology interventions have major ethical deficiencies and need urgent improvement. Professional societies such as TSC are essential institutions to develop and provide guidance and templates for ICFs to meet the ethical standards during the informed consent process and standardization of the process among various institutions.
- 30 April 2021
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 20 (60) , 35-48
Tıp eğitimi sırasında Türk tıp öğrencilerinin uzmanlık tercihlerinde değişiklik
Background: Medical students’ choices depend on their moral values and expectations from their future profession. Although this choice is a personal one it has impacts on the health system. In Turkey, the misdistribution of doctors by specialty has become a significant problem and a risk for the sustainability of the health provision system.Objectives: The aims were to understand how medical students’ up-to-date perceptions and choices of specialization change during their educations, and which moral values have an impact on this process. Material and Methods: An online survey was conducted on 706 medical students. The questionnaire included questions on specialization, career aspirations, the national examination on specialization in medicine (SIM), and compulsory service. After the analysis of this survey, 2 focus groups with a total number of 19 were conducted for further analysis of the data that was collected previously. 50 minutes-long focus group discussions were held on campus between October 24 and October 25, 2019. Findings: Almost all students (98.81%) stated they are planning to get specialty training. Most of the clinical phase students’ (74.01%) specialty preference has changed compared to their first year at medical school. They explained during the focus group sessions that this change was because of their internships during the clinical stage phase (4th, 5th, and 6th year). Significantly more male students stated “financial reasons” as their reason for undergoing specialty training (p=0.016). Focus-group discussions revealed the fact that first three year students tend to choose surgical specialties more, but last three years students tend to choose medical sciences considering their standard of living. Conclusion: We must acknowledge that medical students’ choices on specialization change from surgical specialties towards medical sciences during medical education due to the heavy workload, financial issues, malpractice lawsuits and mobbing. In order to prevent the misdistribution of doctors by specialty, improvement in work conditions should be made.
- 30 April 2021
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 20 (60) , 35-48
Tıp eğitimi sırasında Türk tıp öğrencilerinin uzmanlık tercihlerinde değişiklik
Background: Medical students’ choices depend on their moral values and expectations from their future profession. Although this choice is a personal one it has impacts on the health system. In Turkey, the misdistribution of doctors by specialty has become a significant problem and a risk for the sustainability of the health provision system.Objectives: The aims were to understand how medical students’ up-to-date perceptions and choices of specialization change during their educations, and which moral values have an impact on this process. Material and Methods: An online survey was conducted on 706 medical students. The questionnaire included questions on specialization, career aspirations, the national examination on specialization in medicine (SIM), and compulsory service. After the analysis of this survey, 2 focus groups with a total number of 19 were conducted for further analysis of the data that was collected previously. 50 minutes-long focus group discussions were held on campus between October 24 and October 25, 2019. Findings: Almost all students (98.81%) stated they are planning to get specialty training. Most of the clinical phase students’ (74.01%) specialty preference has changed compared to their first year at medical school. They explained during the focus group sessions that this change was because of their internships during the clinical stage phase (4th, 5th, and 6th year). Significantly more male students stated “financial reasons” as their reason for undergoing specialty training (p=0.016). Focus-group discussions revealed the fact that first three year students tend to choose surgical specialties more, but last three years students tend to choose medical sciences considering their standard of living. Conclusion: We must acknowledge that medical students’ choices on specialization change from surgical specialties towards medical sciences during medical education due to the heavy workload, financial issues, malpractice lawsuits and mobbing. In order to prevent the misdistribution of doctors by specialty, improvement in work conditions should be made.
- Open Access
- 1 January 2020
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Case Reports
- Vol. 28 (1) , 36-40
How Much Resistance is Considered During Prophylaxis Recommendation? A Case Report of Infective Endocarditis with Multi-Drug Resistant Streptococcus Despite Appropriate Prophylaxis Before Dental Intervention
Infective endocarditis is a disease with high mortality and morbidity, generally caused by a wide range of organisms. Prophylaxis with penicillins, cefalosporins, macrolides, or vancomycin is highly recommended for the patients with endocarditis, prosthetic heart valves. An 83-year-old man admitted with fever, fatigue, and joint pain and reported dental intervention following amoxicillin prophylaxis fortyfive days ago. Patient history indicated acute rheumatoid arthritis, bacterial endocarditis, and mitral and aortic valve replacement. S. Sanguinis was detected in the blood culture of the patient, which was resistant to penicillin and ampicillin. He was given meropenem, the clinical status was improved and no microorganisms were detected in two follow-up blood cultures. Endocarditis prophylaxis should be individualized considering the globally high penicillin resistance, especially for the patients with prosthetic valves and/or infective endocarditis history. In addition, to decrease the bacterial load of the oral flora before elective dental or respiratory intervention is recommended with antibiotic prophylaxis.
- 1 January 2020
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Case Reports
- Vol. 28 (1) , 36-40
Open AccessHow Much Resistance is Considered During Prophylaxis Recommendation? A Case Report of Infective Endocarditis with Multi-Drug Resistant Streptococcus Despite Appropriate Prophylaxis Before Dental Intervention
Infective endocarditis is a disease with high mortality and morbidity, generally caused by a wide range of organisms. Prophylaxis with penicillins, cefalosporins, macrolides, or vancomycin is highly recommended for the patients with endocarditis, prosthetic heart valves. An 83-year-old man admitted with fever, fatigue, and joint pain and reported dental intervention following amoxicillin prophylaxis fortyfive days ago. Patient history indicated acute rheumatoid arthritis, bacterial endocarditis, and mitral and aortic valve replacement. S. Sanguinis was detected in the blood culture of the patient, which was resistant to penicillin and ampicillin. He was given meropenem, the clinical status was improved and no microorganisms were detected in two follow-up blood cultures. Endocarditis prophylaxis should be individualized considering the globally high penicillin resistance, especially for the patients with prosthetic valves and/or infective endocarditis history. In addition, to decrease the bacterial load of the oral flora before elective dental or respiratory intervention is recommended with antibiotic prophylaxis.
- Open Access
- 19 October 2019
- Published by Elsevier in Asian Journal of Surgery
- Vol. 43 (3) , 497-503
Does content of informed consent forms make surgeons vulnerable to lawsuits?
- 19 October 2019
- Published by Elsevier in Asian Journal of Surgery
- Vol. 43 (3) , 497-503
Open AccessDoes content of informed consent forms make surgeons vulnerable to lawsuits?
- 16 July 2019
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 35 (4) , 273-279
Evaluation of Ethical Analyses in Seven Reports from the European Network for Health Technology Assessment
Objectives Ethics has been considered among the core domains of health technology assessment (HTA), but there are still disputes regarding ethical analysis. This study aimed to examine full final reports of the European Network for Health Technology Assessment (EUnetHTA) in terms of their compliance with the ethical methodology and ethical perspective of the HTA Core Model (R). Methods The study examines seven full final HTA reports of EUnetHTA written based on the methodology proposed in the HTA Core Model (R). The reports were analyzed using the following parameters: competency of the person/group who conducted ethical analysis, assessment elements, and the methodology of ethical analysis. Results The results show that, although the HTA Core Model (R) helped to standardize the final reports of the assessment, there are still concerns regarding the competency of the ethical analysis team, the perspectives on the purpose of ethical analysis, data sources and viewpoints of various stakeholders, use of ethical analysis methodology, and the evaluation of the ethical appropriateness of the entire HTA process. Conclusions The HTA Core Model (R) helped to standardize the final reports on the HTA; however, not all issues with the content and outcomes were solved. The lack of expertise in ethics and insufficiency of the teams regarding ethical analysis are other existing problems. This study also demonstrated that stakeholder viewpoints in general and patient perspectives, in particular, have been overlooked in the HTA process.
- 16 July 2019
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 35 (4) , 273-279
Evaluation of Ethical Analyses in Seven Reports from the European Network for Health Technology Assessment
Objectives Ethics has been considered among the core domains of health technology assessment (HTA), but there are still disputes regarding ethical analysis. This study aimed to examine full final reports of the European Network for Health Technology Assessment (EUnetHTA) in terms of their compliance with the ethical methodology and ethical perspective of the HTA Core Model (R). Methods The study examines seven full final HTA reports of EUnetHTA written based on the methodology proposed in the HTA Core Model (R). The reports were analyzed using the following parameters: competency of the person/group who conducted ethical analysis, assessment elements, and the methodology of ethical analysis. Results The results show that, although the HTA Core Model (R) helped to standardize the final reports of the assessment, there are still concerns regarding the competency of the ethical analysis team, the perspectives on the purpose of ethical analysis, data sources and viewpoints of various stakeholders, use of ethical analysis methodology, and the evaluation of the ethical appropriateness of the entire HTA process. Conclusions The HTA Core Model (R) helped to standardize the final reports on the HTA; however, not all issues with the content and outcomes were solved. The lack of expertise in ethics and insufficiency of the teams regarding ethical analysis are other existing problems. This study also demonstrated that stakeholder viewpoints in general and patient perspectives, in particular, have been overlooked in the HTA process.
- 10 June 2019
- Published by SAGE Publications in Workplace Health & Safety
- Vol. 67 (9) , 452-460
Health Literacy Level of Casting Factory Workers and Its Relationship With Occupational Health and Safety Training
Health literacy (HL) is a stronger predictor of an individual’s health status than income, employment status, education level, and race or ethnicity. Lower levels of HL may contribute to low uptake or less adherence to occupational health and safety (OHS) training. This study was conducted among casting factory workers who received OHS training routinely. Data on sociodemographic characteristics, OHS training, and scores of the Health Literacy Survey–European Union (HLS-EU) were collected. Of the 282 of the 600 (47%) workers surveyed, 13.5% had inadequate, 47.5% problematic, 30.9% sufficient, and 8.2% excellent HL scores. There were no statistically significant differences between workers with limited and proficient HL with respect to age group or educational level. Workers with limited HL were less satisfied with OHS training content and were less likely to identify one-on-one health and safety training sessions as training. Limited HL is a universal problem both in the general and working populations, and it may be restricting the workers understanding of OHS training. Occupational health nurses should be aware of the detrimental effects of limited HL and modify their OHS training where needed for purposes of increasing the successful adoption of safe work practices.
- 10 June 2019
- Published by SAGE Publications in Workplace Health & Safety
- Vol. 67 (9) , 452-460
Health Literacy Level of Casting Factory Workers and Its Relationship With Occupational Health and Safety Training
Health literacy (HL) is a stronger predictor of an individual’s health status than income, employment status, education level, and race or ethnicity. Lower levels of HL may contribute to low uptake or less adherence to occupational health and safety (OHS) training. This study was conducted among casting factory workers who received OHS training routinely. Data on sociodemographic characteristics, OHS training, and scores of the Health Literacy Survey–European Union (HLS-EU) were collected. Of the 282 of the 600 (47%) workers surveyed, 13.5% had inadequate, 47.5% problematic, 30.9% sufficient, and 8.2% excellent HL scores. There were no statistically significant differences between workers with limited and proficient HL with respect to age group or educational level. Workers with limited HL were less satisfied with OHS training content and were less likely to identify one-on-one health and safety training sessions as training. Limited HL is a universal problem both in the general and working populations, and it may be restricting the workers understanding of OHS training. Occupational health nurses should be aware of the detrimental effects of limited HL and modify their OHS training where needed for purposes of increasing the successful adoption of safe work practices.